Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Why these ASX firms are shying away from the ‘pot stock’ label – Part One
News
In Case You Missed It: TechGen Metals soars 289pc on gold and lithium projects update
Health & Biotech
‘Fully funded’ – MGC Pharma completes share consolidation and ~US$8 million cap raise
Health & Biotech
‘Unwavering Support’: MGC Pharma secures US$7.9 million from investors as looks to advance US FDA IND applications
News
In Case You Missed It: A strategic superannuation partnership takes the lead today
News
Quarterly wrap: YPB metrics continue to improve as it pursues profitability
News
ASX Small Caps Lunch Wrap: Who’s had their world turned upside down this week?
News
Top 10 at 11: It’s a pretty quiet morning, but the metal heads want to turn it up loud
Health & Biotech
Clinical results for ancient therapy help ASX cannabis stocks weed out competition
News
Top 10 at 11: CCE inks €€€ Irish energy deal, Besra finds gold under the gold it found before
Health & Biotech
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…
Health & Biotech
Weed Week: ‘Welcome to the psychedelic 2020s!’ as market holds breath on key US approval
Health & Biotech
MGC Pharma hits another milestone in path to FDA approval for anti-inflammatory CimetraA
Health & Biotech
ASX Health Stocks: Anteris successfully implants aortic valve, MGC Pharma a step closer to FDA submission
Health & Biotech
MGC Pharma nabs import approval for psilocybin to Slovenian research facility
News
